# EDGAR Filing Document

**Accession Number:** 0001773751
**File Stem:** 0001773751-26-000096
**Filing Date:** 2026-6
**Character Count:** 7368
**Document Hash:** ebea40b4225881c965aec92f08e5dbfc
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001773751-26-000096.hdr.sgml**: 20260615

**ACCESSION NUMBER**: 0001773751-26-000096

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 11

**CONFORMED PERIOD OF REPORT**: 20260611

**ITEM INFORMATION**: Submission of Matters to a Vote of Security Holders

**FILED AS OF DATE**: 20260615

**DATE AS OF CHANGE**: 20260615

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Hims & Hers Health, Inc.
- **CENTRAL INDEX KEY:** 0001773751
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-38986
- **FILM NUMBER:** 261091768

**BUSINESS ADDRESS:**
- **STREET 1:** 2269 CHESTNUT ST
- **STREET 2:** #523
- **CITY:** SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94123
- **BUSINESS PHONE:** 415-851-0195

**MAIL ADDRESS:**
- **STREET 1:** 2269 CHESTNUT ST
- **STREET 2:** #523
- **CITY:** SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94123

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Oaktree Acquisition Corp.
- **DATE OF NAME CHANGE:** 20190412

?xml version='1.0' encoding='ASCII'? hims-20260611

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

_____________________________________________________________________________________________________________________

**FORM 8-K**

_____________________________________________________________________________________________________________________

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of the**

**Securities Exchange Act of 1934**

**Date of Report (Date of earliest event reported): June 11, 2026**

_____________________________________________________________________________________________________________________

**HIMS & HERS HEALTH, INC.**

**(Exact name of registrant as specified in its charter)**

_____________________________________________________________________________________________________________________

---

| | | |
|:---|:---|:---|
| **Delaware** | **001-38986** | **98-1482650** |
| **(State or other jurisdiction**<br>**of incorporation)** | **(Commission File Number)** | **(IRS Employer Identification No.)** |

---

**2269 Chestnut Street, #523**

**San Francisco, CA 94123**

**(Address of principal executive offices)**

**(415) 851-0195**

**(Registrant's telephone number, including area code)**

______________________________________________________________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

------

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading symbol** | **Name of each exchange on which registered** |
| Class A Common Stock, $0.0001 par value | HIMS | New York Stock Exchange |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

**Item 5.07. Submission of Matters to a Vote of Security Holders.** 

(a)(b) On June 11, 2026, Hims & Hers Health, Inc. (the "Company") held its Annual Meeting of Stockholders (the "Annual Meeting"). At the Annual Meeting, the Company's stockholders voted on three proposals, each of which is described in more detail in the Company's definitive proxy statement on Schedule 14A filed with the U.S. Securities and Exchange Commission on April 28, 2026.

Only stockholders of record as of the close of business on April 15, 2026, the record date for the Annual Meeting, were entitled to vote at the Annual Meeting. As of the record date, 222,525,754 shares of Company's Class A common stock ("Class A Common Stock") and 8,377,623 shares of the Company's Class V common stock ("Class V Common Stock") were outstanding and entitled to vote at the Annual Meeting. In deciding all matters at the Annual Meeting, the holders of our Class A Common Stock had the right to one vote for each share of Class A Common Stock they held as of the record date and the holders of our Class V Common Stock had the right to 175 votes for each share of Class V Common Stock they held as of the record date. The holders of our Class A Common Stock and Class V Common Stock voted as a single class on all matters presented at the Annual Meeting.

The tabulation of the stockholders' votes on each proposal brought before the Annual Meeting is as follows:

***Proposal 1****: The election of nine directors to serve as directors until the 2027 annual meeting of stockholders and until their respective successors are duly elected and qualified:*

---

| | | | |
|:---|:---|:---|:---|
| **<u>Name</u>** | **<u>For</u>** | **<u>Withheld</u>** | **<u>Broker Non-Votes</u>** |
| Andrew Dudum | 1504939830 | 13028642 | 74228233 |
| Kofi Amoo-Gottfried | 1517440666 | 527806 | 74228233 |
| Deborah Autor | 1516370269 | 1598203 | 74228233 |
| Delos Cosgrove, M.D. | 1516949085 | 1019387 | 74228233 |
| Anja Manuel | 1516973593 | 994879 | 74228233 |
| Christopher Payne | 1508808309 | 9160163 | 74228233 |
| Andrea Perez | 1516871986 | 1096486 | 74228233 |
| Kare Schultz | 1516971244 | 997228 | 74228233 |
| David Wells | 1501758393 | 16210079 | 74228233 |

---

***Proposal 2****: The ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026:*

---

| | | |
|:---|:---|:---|
| **<u>For</u>** | **<u>Against</u>** | **<u>Abstentions</u>** |
| 1,591,246,881 | 516,386 | 433,438 |

---

As a routine proposal under applicable rules, no broker non-votes were recorded in connection with this proposal.

***Proposal 3****: Advisory approval of the Company's executive compensation:*

---

| | | | |
|:---|:---|:---|:---|
| **<u>For</u>** | **<u>Against</u>** | **<u>Abstentions</u>** | **<u>Broker Non-Votes</u>** |
| 1,506,477,171 | 11,181,420 | 309,881 | 74,228,233 |

---

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
| | **HIMS & HERS HEALTH, INC.** | **HIMS & HERS HEALTH, INC.** |
| Date: June 15, 2026 | By: | /s/ Andrew Dudum |
|  |  | Andrew Dudum |
|  |  | Chief Executive Officer |

---